Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

EMA panel recommends Merck, Pfizer’s diabetes drug

A European Medicines Agency (EMA) panel recommended granting marketing approval to the diabetes drug Steglatro developed by Merck & Co. Inc. and Pfizer Inc.

Read More »

AstraZeneca’s three-in-one inhaler helps COPD patients in clinical study

AstraZeneca said an inhaler for chronic obstructive pulmonary disease (COPD) delivered improved lung function in a late-stage trial that could challenge GlaxoSmithKline’s new three-in-one inhaler.

Read More »

Illumina wins patent fight with Roche unit Ariosa

Gene testing company Illumina won a jury verdict in a U.S. lawsuit accusing rival Ariosa Diagnostics, a Roche subsidiary, of using patented prenatal testing technology without authorization.

Read More »

Flu deaths may be less likely with annual vaccination

Seniors who get a flu shot every year are less likely to be hospitalized with severe influenza infections or to die from them than those who get vaccinated only sporadically, a study suggests.

Read More »

Biogen buys IND-ready asset from Karyopharm

Biogen acquired an IND-ready asset from Karyopharm Therapeutics for $10 million upfront.

Read More »

Former Merrimack, Sanofi Execs Launch Boston Cancer Startup

Two former executives of Sanofi and Merrimack Pharmaceuticals launched Partner Therapeutics (PTx) to focus on oncology.

Read More »

Takeda Alzheimer’s Drug Fails Late-Stage Study

Takeda Pharmaceutical and development partner Zinfandel Pharmaceuticals pulled the plug on their five-year Phase III TOMMORROW trial following an interim analysis.

Read More »

Amneal Eyes 400 New Jobs in New York Expansion

Amneal Pharmaceuticals is planning an expansion of its New York facilities that will create hundreds of jobs as the company and Impax Laboratories near completion of a planned merger.

Read More »

“Not All Amyloid Beta Therapeutics Are Created Equal”

ProMIS Neurosciences Inc., a biotechnology company focused on the discovery and development of precision treatments for neurodegenerative diseases, announced it has issued a new scientific white paper entitled: ‘Not all Amyloid Beta Therapeutics are Created Equal’.

Read More »

FDA Approves Trulance for IBS-C in Adults

Synergy Pharmaceuticals Inc. announced that the U.S. FDA approved Trulance (plecanatide) 3-mg tablet for the once-daily treatment of irritable bowel syndrome with constipation in adults.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2018 Focus: Top 50 Pharma, Company of the Year and more!


Ad Right Bottom